Finding Druggable Pathways Affected by the R90H-NCF1 SLE Risk Variants
Betty Tsao, PhDMedical University of South Carolina
The Target Identification in Lupus grants provide up to $200,000/year total costs for up to 3 years. They support highly meritorious research focused on the identification and scientific and/or clinical advancement of therapeutic targets that will lead to new therapies for lupus.